Lappaconitine: Influence of Halogen Substituent on the Antiarrhythmic Activity

ISSN: 1875-6182 (Online)
ISSN: 1871-5257 (Print)

Volume 14, 3 Issues, 2016

Download PDF Flyer

Cardiovascular & Hematological Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Cardiovascular & Hematological Agents

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Debabrata Mukherjee
Department of Internal Medicine Texas Tech University
El Paso, TX

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Lappaconitine: Influence of Halogen Substituent on the Antiarrhythmic Activity

Cardiovascular & Hematological Agents in Medicinal Chemistry, 11(3): 211-217.

Author(s): A. O. Bryzgalov, V. E. Romanov, T. G. Tolstikova and E E Shults.

Affiliation: Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9 Prosp. Akad. Lavrent`eva, 630090 Novosibirsk, Russian Federation.


The current paper presents research results related to antiarrhythmic activity of halogen-containing derivatives of lappaconitine. Lappaconitine derivatives with iodine, chlorine or bromine substituting the anthranilate moiety at C-5` position were shown in vivo and in vitro to exhibit a more (Br, I) or less (Cl) pronounced antiarrhythmic activity in the models of calcium chloride- and adrenaline-induced arrhythmias as compared with the reference compound lappaconitine. The intensity of antiarrhythmic action depending on halogen substituent was found to be expressed by the following order: Cl < I < Br.


Arrhythmia, lappaconitine, halogen-containing lappaconitine derivatives.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 11
Issue Number: 3
First Page: 211
Last Page: 217
Page Count: 7
DOI: 10.2174/18715257113119990083
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science